Navigation Links
DrugRisk Updates with Latest Case Numbers Since Januvia Lawsuits Sent to MDL Court

New York, NY (PRWEB) September 24, 2013

The diabetes drug safety center at is announcing new information on the site for patients taking the medications Januvia or Janumet. A federal multidistrict litigation court recently created to handle lawsuits alleging the drugs caused pancreatic cancer has issued the latest update on case volumes*.

DrugRisk is a resource center created to improve patient safety by giving those taking popular prescription drugs the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Januvia and Janumet are popular oral diabetes medications prescribed to those with type-2 diabetes, taken twice a day to lower blood sugar levels. In recent years, they have been the best-selling drugs for pharmaceutical company Merck**.

However, DrugRisk has added studies warning of a risk of Januvia cancer. In 2011, researchers from UCLA discovered subjects given Januvia had an increased risk of developing pancreatic cancer and thyroid cancer***. The American Medical Association recently advised diabetes drugs like these can double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

Due to the number of patients who have filed a Januvia lawsuit alleging cancer, cases have been consolidated to a special federal multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).

Now, the latest records from the court show 60 people have already filed a Januvia lawsuit or similar action relating to Byetta, Janumet or Victoza*.

Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit

*JPML 9/11/13;
**Bloomberg, 2/25/13;
***Gastroenterology, July 2011;
****JAMA Internal Medicine, 2/25/13;

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Byetta Lawsuits Headed to Special Federal Court
2. DrugRisk Update: Januvia Lawsuits Alleging Cancer Headed to Federal Court
3. DrugRisk Update: Latest Court Order Moves Mirena Lawsuits Forward
4. DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
5. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
6. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
7. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
8. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
9. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
10. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
11. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group ... group of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men ... prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown ... helped advance the healthcare industry as a whole through their advocacy and professional ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... TX (PRWEB) , ... November 26, 2015 , ... PRMA ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! ... “We wake up every day excited to rebuild lives and it’s an honor to ...
(Date:11/25/2015)... BROOK, Ill. (PRWEB) , ... November 25, 2015 ... ... larger and potentially more aggressive than those found on mammography, according to a ... MRI findings of additional cancers not seen on mammography may necessitate a change ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
Breaking Medicine Technology: